🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

148,76 USD

Máx. histórico

156,45

76 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-4,92%

Rango 52 semanas

85,80 – 156,92

Variación hoy

+1,38%

Cierre anterior

146,73

Rango de hoy

146,52 – 148,80

Volumen hoy

7.557.172

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,43%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
150,26 (puede no estar actualizado)
Dividend yield
2,32% (puede no estar actualizado)
Precio objetivo analistas
161,53 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 7 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,29%
Fecha de pago Importe por participación
14/12/2022 0,7300 USD
14/09/2022 0,6900 USD
14/06/2022 0,6900 USD
14/03/2022 0,6900 USD
14/12/2021 0,6900 USD
14/09/2021 0,6500 USD
14/06/2021 0,6500 USD
12/03/2021 0,6202 USD
14/12/2020 0,6202 USD
14/09/2020 0,5821 USD
12/06/2020 0,5821 USD
13/03/2020 0,5821 USD
13/12/2019 0,5821 USD
13/09/2019 0,5248 USD
14/06/2019 0,5248 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
17/08/2023 108,66 110,28 108,32 108,92 +0,17% 1,80% 6.457.800
16/08/2023 108,50 109,47 108,28 108,73 +0,06% 1,10% 5.332.900
15/08/2023 108,89 109,42 108,42 108,66 -0,23% 0,92% 5.118.700
14/08/2023 107,92 109,43 107,31 108,91 +1,37% 1,96% 8.427.200
11/08/2023 105,95 107,71 105,59 107,44 +1,77% 2,00% 5.904.300
10/08/2023 106,21 107,04 105,42 105,57 -0,50% 1,53% 6.525.700
09/08/2023 106,27 106,79 105,79 106,10 -0,29% 0,94% 6.479.500
08/08/2023 105,69 107,19 105,69 106,41 +0,30% 1,42% 10.152.200
07/08/2023 105,29 106,28 104,42 106,09 +1,04% 1,77% 8.259.100
04/08/2023 105,64 106,42 104,51 105,00 -0,69% 1,81% 6.700.700
03/08/2023 105,08 105,78 104,87 105,73 +0,03% 0,87% 6.039.300
02/08/2023 106,03 108,14 104,88 105,70 +0,40% 3,07% 10.873.500
01/08/2023 109,60 109,60 105,14 105,28 -1,28% 4,07% 10.009.200
31/07/2023 106,55 106,77 105,67 106,65 +0,29% 1,03% 7.397.500
28/07/2023 105,43 106,65 105,24 106,34 +1,02% 1,34% 6.903.800
27/07/2023 107,24 107,62 105,17 105,27 -1,75% 2,28% 9.813.100
26/07/2023 106,80 108,01 106,06 107,14 -0,36% 1,83% 7.042.700
25/07/2023 107,64 108,72 107,32 107,53 -1,16% 1,30% 6.498.700
24/07/2023 109,99 110,34 108,50 108,79 -1,45% 1,67% 6.045.500
21/07/2023 108,73 110,62 108,38 110,39 +1,78% 2,06% 8.194.000
20/07/2023 106,55 108,95 106,06 108,46 +2,37% 2,71% 8.073.000
19/07/2023 106,16 107,38 105,91 105,95 +0,00% 1,38% 6.608.600
18/07/2023 105,88 107,03 105,35 105,95 +0,36% 1,59% 7.499.100
17/07/2023 107,04 107,44 105,29 105,57 -1,65% 2,01% 7.376.400
14/07/2023 106,26 107,68 106,26 107,34 +0,96% 1,34% 7.209.900
13/07/2023 107,33 107,91 106,26 106,32 -1,07% 1,54% 9.764.400
12/07/2023 108,37 109,05 107,19 107,47 -1,13% 1,72% 8.376.700
11/07/2023 109,48 110,02 108,25 108,70 -1,15% 1,62% 6.084.400
10/07/2023 109,14 110,60 109,10 109,96 +0,88% 1,37% 5.949.200
07/07/2023 111,07 111,50 108,76 109,00 -2,46% 2,47% 11.316.600